IFNAR2 and coinfection: Although the differences between groups treated with single mAbs versus both mAbs were not statistically significant, there was clear trend towards delayed mortality and overall increased survival in the group inoculated with IFNαβR mAb early after co-infection together with anti-IFN-γ mAb given later.